Study of Vilazodone to Treat Social Anxiety Disorder

Unknown 30 enrolled The Medical Research Network Forest Laboratories · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Vilazodone is effective in the treatment of symptoms of Social Anxiety Disorder among adults.

Timeline

Start: 2012-10
Primary completion: 2014-03
Completion: 2014-04

Outcome

Met primary endpoint

paper vilazodone group had improved significantly more than the placebo group by 14.3 points on the LSAS (t = 1.80, P = .04, one-tail test) PMID 27057414 ↗

Publications

Careri JM, Draine AE, Hanover R, Liebowitz MR. A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder. Prim Care Companion CNS Disord. 2015 Nov 26;17(6):10.4088/PCC.15m01831. doi: 10.4088/PCC.15m01831. eCollection 2015.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vilazodone	Small molecule	20 mg	Oral
Subject	Vilazodone	Small molecule	40 mg	Oral